Back
Summit Therapeutics Stock Predictions
Sponsored
SMMT
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
57
SMMT
Summit Therapeutics
Last Price:
18.44
Seasonality Move:
33.32%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...Summit Therapeutics Stock Forecast
- Over the next 52 weeks, Summit Therapeutics has on average historically risen by 117.1% based on the past 9 years of stock performance.
- Summit Therapeutics has risen higher in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%
-
Is Summit Therapeutics Stock Undervalued?
The current Summit Therapeutics [SMMT] share price is $18.62. The Score for SMMT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal. - SMMT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Summit Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Summit Therapeutics has on average historically risen by 117.1% based on the past 9 years of stock performance.
Summit Therapeutics Stock Rating
Buy
57
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics overpriced?
- Summit Therapeutics has risen higher in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%
Summit Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
smmttx.com
52-Week Data
52-Week High:
33.89
52-Week Low:
1.89
Prediction Charts
Market Cap:
13.73B
Price in USD:
18.62
Volume:
1.77M
Beta:
-0.24
Technical Analysis
SMA50:
21.35
SMA100:
16.18
SMA200:
10.59
52-Wk Change:
835.68%
Stock Predictions
-
Is Summit Therapeutics stock public?
Yes, Summit Therapeutics is a publicly traded company. -
What is the Summit Therapeutics stock quote today?
The Summit Therapeutics stock price is 18.62 USD today. -
How to buy Summit Therapeutics stock online?
You can buy Summit Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Nov-1 | 18.98 | 18.99 | 19.77 | 18.61 |
Nov-4 | 19.41 | 19.96 | 20.56 | 18.80 |
Nov-5 | 20.10 | 20.39 | 20.55 | 19.70 |
Nov-6 | 20.16 | 20.89 | 20.96 | 19.01 |
Nov-7 | 21.19 | 21.10 | 21.68 | 20.26 |
Nov-8 | 21.21 | 21.41 | 21.83 | 20.72 |
Nov-11 | 21.90 | 21.79 | 22.53 | 21.42 |
Nov-12 | 21.56 | 20.76 | 22.25 | 20.74 |
Nov-13 | 21.27 | 19.47 | 21.74 | 19.43 |
Nov-14 | 20.00 | 19.45 | 20.15 | 19.37 |
Nov-15 | 19.45 | 18.31 | 19.45 | 18.23 |
Nov-18 | 18.36 | 18.98 | 19.25 | 18.11 |
Nov-19 | 18.72 | 20.00 | 20.14 | 18.50 |
Nov-20 | 19.91 | 18.62 | 19.97 | 18.31 |
Summit Therapeutics Earnings
Summit Therapeutics Earnings Report: Per Share Summit Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Summit Therapeutics Forecast Revenue Growth
Summit Therapeutics Stock Analysis: Historical quarterly revenues per share for Summit Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and a decrease next year of $0.08 per share.
* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.